Report on Carcinogens Webinar on Trichloroethylene; Notice of Public Webinar and Registration Information, 7218-7219 [2014-02455]

Download as PDF 7218 Federal Register / Vol. 79, No. 25 / Thursday, February 6, 2014 / Notices Contact Person: Manana Sukhareva, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Room 959, Bethesda, MD 20892, 301–451–3397, sukharem@mail.nih.gov. Dated: January 31, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–02458 Filed 2–5–14; 8:45 am] BILLING CODE 4140–01–P Contact Person: Robert Wellner, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 706, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, rw175w@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS). Dated: January 31, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2014–02457 Filed 2–5–14; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Initial Review Group; Digestive Diseases and Nutrition C Subcommittee. Date: March 13–14, 2014. Open: March 13, 2014, 8:00 a.m. to 8:30 a.m. Agenda: To review policy and procedures. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: March 13, 2014, 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Closed: March 14, 2014, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. VerDate Mar<15>2010 18:18 Feb 05, 2014 Jkt 232001 National Institutes of Health Report on Carcinogens Webinar on Trichloroethylene; Notice of Public Webinar and Registration Information The National Toxicology Program (NTP) announces a public webinar, ‘‘Human Cancer Studies on Exposure to Trichloroethylene (TCE): Methods Used To Assess Exposure and Cancer Outcomes.’’ The Office of the Report on Carcinogens (ORoC), Division of the NTP (DNTP), National Institute of Environmental Health Sciences (NIEHS) will hold the webinar using Adobe® ConnectTM, and the public can register to attend. DATES: Webinar: March 17, 2014, 9:00 a.m. to approximately 1:00 p.m. Eastern Daylight Time (EDT). Registration for Webinar: February 6, 2014 through March 13, 2014. Availability of Webinar Materials: March 3, 2014. ADDRESSES: Webinar Web page: https:// ntp.niehs.nih.gov/go/tcewebinar. FOR FURTHER INFORMATION CONTACT: Dr. Ruth M. Lunn, Director, ORoC, DNTP, NIEHS, P.O. Box 12233, MD K2–14, Research Triangle Park, NC 27709. Phone: (919) 316–4637; Fax: (301) 480– 2970, Email: lunn@niehs.nih.gov. Hand Delivery/Courier: 530 Davis Drive, Room 2138, Morrisville, NC 27560. SUPPLEMENTARY INFORMATION: Background: The Report on Carcinogens (RoC) is a congressionally mandated, science-based, public health report that identifies agents, substances, mixtures, or exposures (collectively called ‘‘substances’’) in our environment that are cancer hazards for people living in the United States. The NTP prepares the RoC on behalf of the Secretary of SUMMARY: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Health and Human Services following an established, four-part process (https:// ntp.niehs.nih.gov/go/rocprocess) and using established criteria (https://ntp. niehs.nih.gov/go/15209). Trichloroethylene (TCE) is a chlorinated alkene used primarily as a metal degreaser and is currently listed as reasonably anticipated to be a human carcinogen in the RoC. The NTP selected TCE for re-review for possible change in listing status in the RoC following solicitation of public comment and review by the NTP Board of Scientific Counselors on June 21–22, 2012 (https://ntp.niehs.nih.gov/go/9741) (for more information on the status of the NTP review of TCE see https://ntp. niehs.nih.gov/go/37899). The purpose of this webinar is (1) to obtain external scientific input, focusing on issues related to the assessment of information (exposure and cancer outcomes) in epidemiologic studies of TCE, which will be used to inform the NTP’s evaluation of the level of evidence from human cancer studies of TCE exposure, and (2) to obtain public input on the protocol for preparation of the draft RoC monograph on TCE. The first part of the webinar will consist of three presentations, with a short question-and-answer period after each presentation, followed by a general discussion session on scientific issues across all presentations. The goals of the individual presentations are (1) to address the adequacy of methods used in the epidemiologic studies to assess exposure and cancer outcomes (primarily lymphohematopoietic cancers), (2) to discuss and compare reported or estimated exposure levels or exposure prevalence across studies, (3) to discuss how this information (e.g., data from TCE exposure assessments, quality of exposure assessment, TCE exposure levels or prevalence, classification of non-Hodgkin lymphoma) is used in the epidemiologic studies and can be used to inform the cancer evaluation across studies. The second part of the webinar will be a discussion session when the public can either make comments on or ask questions about the proposed protocol for preparation of the draft RoC monograph on TCE (https://ntp.niehs. nih.gov/NTP/roc/thirteenth/Protocols/ TCE_Protocol12-31-13_508.pdf). Webinar and Registration: The webinar is scheduled for March 17, 2014, from 9:00 a.m. to approximately 1 p.m. EDT. The webinar may end early if the presentations and discussions are finished. Registration for the webinar is required and is open from February 6, 2014 through March 13, 2014, at https://ntp.niehs.nih.gov/go/pcpwebinar. E:\FR\FM\06FEN1.SGM 06FEN1 Federal Register / Vol. 79, No. 25 / Thursday, February 6, 2014 / Notices Registrants will receive instructions by email on accessing the webinar (via Adobe® ConnectTM) on or before March 14, 2014. The preliminary agenda, list of speakers, and abstracts of the presentations should be posted on the NTP Web site (https://ntp.niehs.nih.gov/ go/tcewebinar) by March 3, 2014. Registrants are encouraged to access the webinar Web page to stay abreast of the most current information regarding this event. Any updates will be posted to the Web page. The protocol for preparing the draft RoC monograph on TCE is available on the RoC Web site for TCE (https://ntp.niehs.nih.gov/go/37899). Public Participation: As noted above, the meeting format includes time after each presentation and during the two discussion sessions for the public to ask questions or make brief remarks. Instructions for public access and participation in the meeting via Adobe® ConnectTM will be emailed to registered attendees. Individuals with disabilities who need accommodation to participate in this event should contact Dr. Lunn (see FOR FURTHER INFORMATION CONTACT). TTY users should contact the Federal TTY Relay Service at 800–877–8339. Requests should be made at least five business days in advance of the event. Background Information on the RoC: Published biennially, each edition of the RoC is cumulative and consists of substances newly reviewed in addition to those listed in previous editions. The 12th RoC, the latest edition, was published on June 10, 2011 (available at https://ntp.niehs.nih.gov/go/roc12). The 13th RoC is under development. Dated: January 31, 2014. John R. Bucher, Associate Director, National Toxicology Program. [FR Doc. 2014–02455 Filed 2–5–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Institute on Drug Abuse; Amended Notice of Meeting Notice is hereby given of changes in the meeting of the National Institute on Drug Abuse Special Emphasis Panel, February 19, 2014, 08:00 a.m. to February 20, 2014, 05:00 p.m., Hilton Garden Inn, 7301 Waverly Street, Bethesda, MD 20814 which was published in the Federal Register on January 22, 2014, 79, 15 FR 2014–01189. The date and time of the meeting are changed to February 19, 2014, 08:00 VerDate Mar<15>2010 18:18 Feb 05, 2014 Jkt 232001 a.m. to February 19, 2014, 06:00 p.m. The meeting is closed to the public. Dated: January 14, 2014. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–02459 Filed 2–5–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflicts: Kidney and Urological Physiology and Pathophysiology. Date: February 27, 2014. Time: 1:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Martha Garcia, Ph.D., Scientific Reviewer Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD 20892, 301–435– 1243, garciamc@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Risk, Prevention and Intervention for Addictions Overflow. Date: March 3–4, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Palomar Hotel, 2121 P Street NW., Washington, DC 20037. Contact Person: Kristen Prentice, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD 20892, 301–496– 0726, prenticekj@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Basic and Integrative Bioengineering. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 7219 Date: March 5, 2014. Time: 8:30 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington National Airport, 1489 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Paul Sammak, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6185, MSC 7892, Bethesda, MD 20892, 301–435– 0601, sammakpj@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group; Host Interactions with Bacterial Pathogens Study Section. Date: March 6, 2014. Time: 7:45 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Sir Francis Drake Hotel, 450 Powell Street at Sutter, San Francisco, CA 94102. Contact Person: Fouad A El-Zaatari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3186, MSC 7808, Bethesda, MD 20892, (301) 435– 1149, elzaataf@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Drug Discovery for the Nervous System Study Section. Date: March 6–7, 2014. Time: 8:00 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Mary Custer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435– 1164, custerm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Investigations on Primary Immunodeficiency Diseases. Date: March 6, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101. Contact Person: Scott Jakes, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301–495– 1506, jakesse@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cardiovascular Sciences. Date: March 6–7, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Washington DC, Dupont Circle, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Margaret Chandler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4126, E:\FR\FM\06FEN1.SGM 06FEN1

Agencies

[Federal Register Volume 79, Number 25 (Thursday, February 6, 2014)]
[Notices]
[Pages 7218-7219]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02455]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Report on Carcinogens Webinar on Trichloroethylene; Notice of 
Public Webinar and Registration Information

SUMMARY: The National Toxicology Program (NTP) announces a public 
webinar, ``Human Cancer Studies on Exposure to Trichloroethylene (TCE): 
Methods Used To Assess Exposure and Cancer Outcomes.'' The Office of 
the Report on Carcinogens (ORoC), Division of the NTP (DNTP), National 
Institute of Environmental Health Sciences (NIEHS) will hold the 
webinar using Adobe[supreg] Connect\TM\, and the public can register to 
attend.

DATES: 
    Webinar: March 17, 2014, 9:00 a.m. to approximately 1:00 p.m. 
Eastern Daylight Time (EDT).
    Registration for Webinar: February 6, 2014 through March 13, 2014.
    Availability of Webinar Materials: March 3, 2014.

ADDRESSES: Webinar Web page: https://ntp.niehs.nih.gov/go/tcewebinar.

FOR FURTHER INFORMATION CONTACT: Dr. Ruth M. Lunn, Director, ORoC, 
DNTP, NIEHS, P.O. Box 12233, MD K2-14, Research Triangle Park, NC 
27709. Phone: (919) 316-4637; Fax: (301) 480-2970, Email: 
lunn@niehs.nih.gov. Hand Delivery/Courier: 530 Davis Drive, Room 2138, 
Morrisville, NC 27560.

SUPPLEMENTARY INFORMATION: 
    Background: The Report on Carcinogens (RoC) is a congressionally 
mandated, science-based, public health report that identifies agents, 
substances, mixtures, or exposures (collectively called ``substances'') 
in our environment that are cancer hazards for people living in the 
United States. The NTP prepares the RoC on behalf of the Secretary of 
Health and Human Services following an established, four-part process 
(https://ntp.niehs.nih.gov/go/rocprocess) and using established criteria 
(https://ntp.niehs.nih.gov/go/15209).
    Trichloroethylene (TCE) is a chlorinated alkene used primarily as a 
metal degreaser and is currently listed as reasonably anticipated to be 
a human carcinogen in the RoC. The NTP selected TCE for re-review for 
possible change in listing status in the RoC following solicitation of 
public comment and review by the NTP Board of Scientific Counselors on 
June 21-22, 2012 (https://ntp.niehs.nih.gov/go/9741) (for more 
information on the status of the NTP review of TCE see https://ntp.niehs.nih.gov/go/37899).
    The purpose of this webinar is (1) to obtain external scientific 
input, focusing on issues related to the assessment of information 
(exposure and cancer outcomes) in epidemiologic studies of TCE, which 
will be used to inform the NTP's evaluation of the level of evidence 
from human cancer studies of TCE exposure, and (2) to obtain public 
input on the protocol for preparation of the draft RoC monograph on 
TCE. The first part of the webinar will consist of three presentations, 
with a short question-and-answer period after each presentation, 
followed by a general discussion session on scientific issues across 
all presentations. The goals of the individual presentations are (1) to 
address the adequacy of methods used in the epidemiologic studies to 
assess exposure and cancer outcomes (primarily lymphohematopoietic 
cancers), (2) to discuss and compare reported or estimated exposure 
levels or exposure prevalence across studies, (3) to discuss how this 
information (e.g., data from TCE exposure assessments, quality of 
exposure assessment, TCE exposure levels or prevalence, classification 
of non-Hodgkin lymphoma) is used in the epidemiologic studies and can 
be used to inform the cancer evaluation across studies. The second part 
of the webinar will be a discussion session when the public can either 
make comments on or ask questions about the proposed protocol for 
preparation of the draft RoC monograph on TCE (https://ntp.niehs.nih.gov/NTP/roc/thirteenth/Protocols/TCE_Protocol12-31-13_508.pdf).
    Webinar and Registration: The webinar is scheduled for March 17, 
2014, from 9:00 a.m. to approximately 1 p.m. EDT. The webinar may end 
early if the presentations and discussions are finished. Registration 
for the webinar is required and is open from February 6, 2014 through 
March 13, 2014, at https://ntp.niehs.nih.gov/go/pcpwebinar.

[[Page 7219]]

Registrants will receive instructions by email on accessing the webinar 
(via Adobe[supreg] Connect\TM\) on or before March 14, 2014.
    The preliminary agenda, list of speakers, and abstracts of the 
presentations should be posted on the NTP Web site (https://ntp.niehs.nih.gov/go/tcewebinar) by March 3, 2014. Registrants are 
encouraged to access the webinar Web page to stay abreast of the most 
current information regarding this event. Any updates will be posted to 
the Web page. The protocol for preparing the draft RoC monograph on TCE 
is available on the RoC Web site for TCE (https://ntp.niehs.nih.gov/go/37899).
    Public Participation: As noted above, the meeting format includes 
time after each presentation and during the two discussion sessions for 
the public to ask questions or make brief remarks. Instructions for 
public access and participation in the meeting via Adobe[supreg] 
Connect\TM\ will be emailed to registered attendees. Individuals with 
disabilities who need accommodation to participate in this event should 
contact Dr. Lunn (see FOR FURTHER INFORMATION CONTACT). TTY users 
should contact the Federal TTY Relay Service at 800-877-8339. Requests 
should be made at least five business days in advance of the event.
    Background Information on the RoC: Published biennially, each 
edition of the RoC is cumulative and consists of substances newly 
reviewed in addition to those listed in previous editions. The 12th 
RoC, the latest edition, was published on June 10, 2011 (available at 
https://ntp.niehs.nih.gov/go/roc12). The 13th RoC is under development.

    Dated: January 31, 2014.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2014-02455 Filed 2-5-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.